---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-024387"
form_type: "8-K"
ticker: "DMII"
cik: "0002040475"
company_name: "Drugs Made In America Acquisition II Corp."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T19:05:05.258883+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# DMIIU CEO Lynn Stockwell resigns after Sponsor fails to repay $566K overpayment; Roger Bendelac appointed CEO

## Summary
- Lynn Stockwell resigned as CEO, Executive Chair, and Board member on Feb 28, 2026, after Board learned Sponsor could not repay $566,269 overpayment.
- Board accepted resignation and removed Stockwell from all positions effective Feb 28, 2026.
- Roger Bendelac, 69, with 30+ years in investment banking and advisory, appointed CEO effective Feb 28, 2026.
- Sponsor withdrew $1.1M from working capital; $566K+ used for expenses unrelated to the Company and not repaid.
- Bendelac's compensation not yet determined; Board will consider and disclose terms later.

## SEC filing metadata
- accession: 0001213900-26-024387
- form_type: 8-K
- ticker: DMII
- cik: 0002040475
- company_name: Drugs Made In America Acquisition II Corp.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/0001213900-26-024387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/ea0280265-8k_drugs2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-024387
- JSON: https://secwatch.observer/filing/0001213900-26-024387.json
- Plain text: https://secwatch.observer/filing/0001213900-26-024387.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.